The Glucose Sensors program will contain projects aimed at developing or implementing glucose sensors that can determine glucose concentration in the plasma, interstitial fluid or other appropriate space in diabetic patients continuously or in repeated samples. This program also includes development of the necessary components of glucose sensors (such as biocompatible materials or fluorescent glucose ligands, new sampling systems, etc.), software, mathematical algorithms and circuitry designed for calibration or insulin pump control, and devices that combine these sensors with insulin delivery systems in a ‘closed-loop’ artificial pancreas.
For more information, contact Dr. Guillermo Arreaza-Rubin, Director, Clinical Immunology, Type 1 Diabetes Program.